Clinical trials that involve use of a new medicine require approval under Section 30 of the Medicines Act 1981. The HRC's Standing Committee on Therapeutic Trials (SCOTT) undertakes scientific assessment of applications to conduct trials and makes recommendations to the Director-General of Health on whether or not trials should be approved.
Committee members:
Associate Professor Richard Robson - Chair
Christchurch Clinical Studies Trust
Professor Carl Burgess
Wellington School of Medicine
Associate Professor Murray Barclay
Department of Clinical Pharmacology, Christchurch Hospital
Associate Professor Chris Frampton
Christchurch School of Medicine and Health Sciences
Associate Professor Mark McKeage
Department of Pharmacology and Clinical Pharmacology, The University of Auckland
Dr Damien Pethica
Auckland
Professor Paul Smith
School of Medical Sciences, University of Otago, Dunedin
Mr Trevor Speight
Auckland
Professor Ian Tucker
School of Pharmacy, University of Otago, Dunedin
Dr Sisira Jayathissa
Hutt Valley District Health Board, Wellington
Dr Stephen Duffull
School of Pharmacy, University of Otago, Dunedin
Ex Officio Members:
Dr Stewart Jessamine
Medsafe, Public Health Directorate, Ministry of Health
Dr Robin Olds
Health Research Council of New Zealand
Committee Secretary: Susan Isaacs
